Percentage of subjects on placebo vs peanut SLIT who pass the 54 month double blind, placebo controlled food challenge to assess tolerance. 54 months [clinicaltrials_resource:ca9cf83e329019e769002f919bab5a20]
All subjects will receive peanut SLIT upon enrollment for the first 48 months. After the desensitization DBPCFC at 48 months, subjects will be randomized 2:1 to placebo or continued peanut SLIT. The SLIT group will complete 60 months of SLIT prior to undergoing a final DBPCFC at 66 months to assess clinical tolerance.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Percentage of subjects on placebo vs peanut SLIT who pass the 54 month double blind, placebo controlled food challenge to assess tolerance. 54 months [clinicaltrials_resource:ca9cf83e329019e769002f919bab5a20]
All subjects will receive peanut SLIT upon enrollment for the first 48 months. After the desensitization DBPCFC at 48 months, subjects will be randomized 2:1 to placebo or continued peanut SLIT. The SLIT group will complete 60 months of SLIT prior to undergoing a final DBPCFC at 66 months to assess clinical tolerance.
Bio2RDF identifier
ca9cf83e329019e769002f919bab5a20
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ca9cf83e329019e769002f919bab5a20
measure [clinicaltrials_vocabulary:measure]
Percentage of subjects on plac ...... challenge to assess tolerance.
time frame [clinicaltrials_vocabulary:time-frame]
description
All subjects will receive pean ...... to assess clinical tolerance.
identifier
clinicaltrials_resource:ca9cf83e329019e769002f919bab5a20
title
Percentage of subjects on plac ...... to assess tolerance. 54 months
@en
type
label
Percentage of subjects on plac ...... cf83e329019e769002f919bab5a20]
@en